We are international
Donate
research TEXT SIZE   
Citings - Novel Therapies

The IMF is pleased to bring you CITINGS - Novel Therapies, a quarterly publication featuring the most up-to-date information on research advances and new therapies for the treatment for multiple myeloma. CITINGS - Novel Therapies provides physicians and other health care professionals with references and Internet links to the most current U.S. and international journal articles, abstracts, and white papers. Each issue presents articles related to new drugs, either as the focus of the study or as part of the discussion of myeloma treatment.

CITINGS - Novel Therapies
    next      view all

ASCO Special Edition: Freelite/Hevylite Issue

Special Presentations Edition: ASCO 2010 Q2/2010

Volume VII, Issue II, Q2/2010: Novel Therapies Publications May 2010

Volume VII, Issue I, QI/2010: Novel Therapies Publications March 2010

ASH 2009 Volume VI, Issue IV, Q4/2009: VELCADE® (bortezomib) Issue

ASH 2009 Volume VI, Issue V, Q4/2009: Novel Therapies Issue

Special ASH Edition: Serum Free Light Chain Assays – ASH 2009 Issue

Volume VI, Issue III, Q3/2009: Thalidomide and Revlimid® Issue

Volume VI, Issue III, Q3/2009: VELCADE® (bortezomib) Issue

ASCO Special Edition, Q2/2009: Thalidomide and Revlimid® Issue

    next      view all